Medicinal product name Seretide 25/50 microgram/dose pressurised inhalation, suspension
Pharmaceutical form Pressurised inhalation, suspension
Strength 25/50 μg/dose 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
01-0451-01 KZSRN120 Is available
Legal status Rx Prescription (Pr.)
KZSR Reimbursed medicines reference product
Package leafletMS Word document 29-03-2022
Summary of product characteristicsMS Word document 29-03-2022
ATC code R03AK06 Drugs for obstructive airway diseases

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(47 containers)
Jelgavfarm, Tamro N120
(25 µg/50 µg/dose)
Aluminium 27.79 
KZSR*
01-0451-01 Labelling text Labelling text Mar 29, 2022
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 01-0451
Date of authorisation Dec 19, 2001
Marketing authorisation holder, country GlaxoSmithKline Trading Services Limited, Ireland